Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (1-10 of 508) with videos related to

Pageof 51
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 14, 2023
[Psychedelic Drugs: Past, Present, and Future]Hiroyuki Uchida
Psychiatry and Clinical Neurosciences|February 14, 2018
Neuroscience-based Nomenclature: What is it, why is it needed, and what comes next?Hiroyuki Uchida
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 28, 2012
[Tips on how to publish your data in English]Hiroyuki Uchida
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Drugs in the Developmental Stage (Psychotropics)]Hiroyuki Uchida
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 16, 2015
Cardiac Sudden Death in Psychiatric PatientsHiroyuki Uchida, Takefumi Suzuki
Psychiatry Research|September 10, 2014
Successful withdrawal from antipsychotic treatment in elderly male inpatients with schizophrenia--description of four cases and review of the literatureTakefumi Suzuki, Hiroyuki Uchida
Journal of Neural Transmission (Vienna, Austria : 1996)|July 9, 2020
Prefrontal cortex hypoactivity distinguishes severe from mild-to-moderate social anxiety as revealed by a palm-sized near-infrared spectroscopy systemHiroyuki Uchida, Kazuki Hirao
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|August 11, 2016
[Newly developed nomenclature (Neuroscience-based Nomenclature)]Hiroyuki Uchida, Shigeto Yamawaki
Journal of Clinical Psychopharmacology|May 1, 2014
Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implicationsHiroyuki Uchida, Takefumi Suzuki
Journal of Clinical Psychopharmacology|December 2, 2024
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension TrialHiroyoshi Takeuchi, Hiroyuki Uchida
Pageof 51

Showing results (1-10 of 508) with videos related to

Sort By:
Pageof 51
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 14, 2023
[Psychedelic Drugs: Past, Present, and Future]Hiroyuki Uchida
Psychiatry and Clinical Neurosciences|February 14, 2018
Neuroscience-based Nomenclature: What is it, why is it needed, and what comes next?Hiroyuki Uchida
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 28, 2012
[Tips on how to publish your data in English]Hiroyuki Uchida
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Drugs in the Developmental Stage (Psychotropics)]Hiroyuki Uchida
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 16, 2015
Cardiac Sudden Death in Psychiatric PatientsHiroyuki Uchida, Takefumi Suzuki
Psychiatry Research|September 10, 2014
Successful withdrawal from antipsychotic treatment in elderly male inpatients with schizophrenia--description of four cases and review of the literatureTakefumi Suzuki, Hiroyuki Uchida
Journal of Neural Transmission (Vienna, Austria : 1996)|July 9, 2020
Prefrontal cortex hypoactivity distinguishes severe from mild-to-moderate social anxiety as revealed by a palm-sized near-infrared spectroscopy systemHiroyuki Uchida, Kazuki Hirao
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|August 11, 2016
[Newly developed nomenclature (Neuroscience-based Nomenclature)]Hiroyuki Uchida, Shigeto Yamawaki
Journal of Clinical Psychopharmacology|May 1, 2014
Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implicationsHiroyuki Uchida, Takefumi Suzuki
Journal of Clinical Psychopharmacology|December 2, 2024
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension TrialHiroyoshi Takeuchi, Hiroyuki Uchida
Pageof 51